Quick Answer
Bone Biologics Corp reported Common Stock Shares Outstanding of 1.80 million shares for the year ending 2025.
- Bone Biologics Corp showed an increase of +264.6% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Bone Biologics Corp's annual report (Form 10-K), filed with the SEC on March 2, 2026.
- XBRL data for this metric is available from 2010 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2010 to 2025), Bone Biologics Corp's Common Stock Shares Outstanding has declined by 64.1%.
- Historical annual values: Fiscal year 2025: 1.80 million shares | Fiscal year 2024: 492,417 shares | Fiscal year 2023: 534,238 shares | Fiscal year 2022: 63,820 shares | Fiscal year 2021: 10.35 million shares | Fiscal year 2020: 12.27 million shares | Fiscal year 2019: 30.68 million shares | Fiscal year 2018: 26.45 million shares | Fiscal year 2017: 4.33 million shares | Fiscal year 2016: 38.83 million shares | Fiscal year 2015: 32.21 million shares | Fiscal year 2014: 24.27 million shares | Fiscal year 2013: 10.93 million shares | Fiscal year 2013: 5.00 million shares | Fiscal year 2012: 5.00 million shares | Fiscal year 2011: 5.00 million shares | Fiscal year 2010: 5.00 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: